PharmaEssentia Corporation (TPE:6446)
657.00
-7.00 (-1.05%)
Mar 13, 2026, 1:30 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 243.85 billion as of March 13, 2026. Its market cap has decreased by -4.49% in one year.
Market Cap
243.85B
Enterprise Value
222.01B
Revenue
15.63B
Ranking
n/a
PE Ratio
48.34
Stock Price
657.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 243.85B, an increase of 519.16%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 243.85B | 40.28% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 71.79B |
| Bora Pharmaceuticals | 58.73B |
| Center Laboratories | 33.15B |
| TTY Biopharm Company | 20.49B |
| Grape King Bio | 17.85B |
| ScinoPharm Taiwan | 17.00B |
| Synmosa Biopharma | 15.67B |
| YungShin Global Holding | 14.22B |